Slowly absorbable mesh in contaminated incisional hernia repair: results of a French multicenter study - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Hernia Année : 2021

Slowly absorbable mesh in contaminated incisional hernia repair: results of a French multicenter study

Diane Charleux-Muller
  • Fonction : Auteur
  • PersonId : 1130752
Romane Hurel
  • Fonction : Auteur
Cecile Brigand
  • Fonction : Auteur
  • PersonId : 1044626
Serge Rohr
  • Fonction : Auteur
  • PersonId : 1114224
Simone Manfredelli
  • Fonction : Auteur
Guillaume Passot
  • Fonction : Auteur
Pablo Ortega-Deballon
  • Fonction : Auteur
Vincent Dubuisson
  • Fonction : Auteur
Yohann Renard
  • Fonction : Auteur
Benoît Romain
  • Fonction : Auteur
  • PersonId : 1128827

Résumé

PURPOSE: To analyze the postoperative morbidity and 1-year recurrence rate of incisional hernia repair using a biosynthetic long-term absorbable mesh in patients at higher risk of surgical infection in a contaminated surgical field. METHODS: All patients undergoing incisional hernia repair in a contaminated surgical field with the use of a biosynthetic long-term absorbable mesh (Phasix®) between May 2016 and September 2018 at six participating university centers were included in this retrospective cohort and were followed-up until September 2019. Regarding the risk of surgical infection, patients were classified according to the modified Ventral Hernia Working Group classification. Preoperative, operative and postoperative data were collected. All patients' surgical site infections (SSIs) and occurrences (SSOs) and recurrence rates were the endpoints of the study. RESULTS: Two hundred and fifteen patients were included: 170 with mVHWG grade 3 (79%) and 45 with mVHWG grade 2 (21%). The SSI and SSO rates at 12 months were 22.3% and 39.5%, respectively. According to the Dindo-Clavien classification, 43 patients (20.0%) had at least one minor complication, and 57 patients (26.5%) had at least one major complication. Among the 121 patients (56.3%) having at least 1 year of follow-up, the clinical recurrence rate was 12.4%. Multivariate analysis showed that a concomitant gastrointestinal procedure was an independent risk factor for surgical infection (OR = 2.61), and an emergency setting was an independent risk factor for major complications (OR = 11.9). CONCLUSION: The use of a biosynthetic absorbable mesh (Phasix®) is safe in a contaminated surgical field, with satisfying immediate postoperative and 1-year results. TRIAL REGISTRATION: The study is registered on Clinical Trial ID: NCT04132986.
Fichier non déposé

Dates et versions

hal-03615858 , version 1 (21-03-2022)

Identifiants

Citer

Diane Charleux-Muller, Romane Hurel, Thibaut Fabacher, Cecile Brigand, Serge Rohr, et al.. Slowly absorbable mesh in contaminated incisional hernia repair: results of a French multicenter study. Hernia, 2021, 25 (4), pp.1051-1059. ⟨10.1007/s10029-020-02366-5⟩. ⟨hal-03615858⟩
36 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More